Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellebrite DI Ltd. covers the month of November 2023, with the report dated December 1, 2023. The filing serves to announce the results of a special general meeting of shareholders held on November 29, 2023.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding shareholder voting and does not contain financial performance data.
Material Changes
The primary material event reported is the shareholder approval of a specific Proposal. The filing does not detail material changes to financial operations or comparative period performance.
Shareholder Meeting Results
- Proposal Approval: Shareholders approved the Proposal by the requisite majority under Israeli Companies Law and the Company's articles of association.
- Attendance: 166,529,976 ordinary shares were present or represented by proxy.
- Ownership Representation: Attending shares represented approximately 82.86% of the issued and outstanding ordinary shares as of the record date.
- Reference: Details of the Proposal are contained in the Proxy Statement filed as Exhibit 99.1 to a Form 6-K dated October 24, 2023.
Outlook, Risks, and Contingencies
The filing text does not provide a clear value for future guidance, management commentary on outlook, specific risks, or contingencies beyond the successful completion of the shareholder vote.
Key Facts for Investor Verification
- Verify the specific content of the "Proposal" approved by shareholders by reviewing the Proxy Statement (Exhibit 99.1) filed on October 24, 2023.
- Confirm the impact of the approved Proposal on the Company's capital structure or governance, as the current filing only confirms the vote outcome.
- Note that this filing incorporates by reference into registration statements on Form S-8 and Form F-3.